Mural Oncology plc

NASDAQ:MURA  
2.06
-0.01 (-0.48%)
6:49:56 PM EDT: $2.06 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Mural Oncology plc Stock, NASDAQ:MURA

10 Earlsfort Terrace, Dublin, Dublin 2
Ireland
Phone: +353.1.905.8020
Number of Employees: 116
http://www.muraloncology.com

Description

Mural Oncology Plc is a clinical-stage oncology company, which engages in the business of discovering and developing immunotherapies for patients with cancer. Its lead product candidate is the Nemvaleukin Alfa which is an interleukin-2 cytokine designed to capture and expand therapeutic benefits of high-dose recombinant human IL-2. The company was founded on May 31, 2017 and is headquartered in Dublin, Ireland.